Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(20%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_2
2
20%
Ph phase_3
1
10%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Terminated(2)

Detailed Status

Completed6
Terminated1
Active, not recruiting1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
2
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

terminated110%
active_not_recruiting110%
completed660%
recruiting110%
withdrawn110%

Recent Activity

2 active trials
Showing 5 of 10
recruitingphase_2

Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC

NCT03872661
completednot_applicable

Evaluation of the Safety and Effectiveness of the Tri-staple Technology inThoracic Surgery Clinical Investigation

NCT07354854
withdrawnphase_2

Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.

NCT03623776
active_not_recruiting

National Register Studies in Thoracic Surgery

NCT03567538
completed

Sensory Changes Associated With Thoracic Surgery

NCT06420570
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT03872661Phase 2

Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC

Recruiting
NCT07354854Not Applicable

Evaluation of the Safety and Effectiveness of the Tri-staple Technology inThoracic Surgery Clinical Investigation

Completed
NCT03623776Phase 2

Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.

Withdrawn
NCT03567538

National Register Studies in Thoracic Surgery

Active Not Recruiting
NCT06420570

Sensory Changes Associated With Thoracic Surgery

Completed
NCT03498352

Rest Ventilatory Parameters Predict Morbidity and Mortality in Thoracic Surgery

Completed
NCT00006183Phase 3

Comparison of Hematocrit Levels in Infant Heart Surgery

Completed
NCT01177215

Investigation of an Adaptive Treatment Algorithm for Post-op Thoracic Patients to Reduce the Length of Drainage

Terminated
NCT01517386

Photonic Needle and Paravertebral Space Detection

Completed
NCT01144845

Chronic Pain Following Thoracic Surgery

Completed

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10